Evaluating a new treatment for antibiotic-resistant tuberculosis
Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant Tuberculosis
This study is looking at a new treatment for antibiotic-resistant tuberculosis to see how well it works and how safe it is for patients, so we can find better options for people dealing with this tough infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icon Government and Public Health Solutions, INC. NIH-funded |
| Lab location | 1 site (Hinckley, United States) |
| Project ID | NIH-11166262 on NIH RePORTER |
What this research studies
This research investigates a new therapeutic approach for treating antibiotic-resistant tuberculosis by evaluating how the drug is processed in the body and its safety profile. Patients will be monitored closely during the trial to assess the drug's effectiveness and any potential side effects. The study aims to provide critical data that could lead to improved treatment options for those suffering from this challenging infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with antibiotic-resistant tuberculosis.
Not a fit: Patients who do not have tuberculosis or those with drug-sensitive strains of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with antibiotic-resistant tuberculosis.
How similar studies have performed: Other research has shown promise in developing new treatments for antibiotic-resistant infections, indicating potential for success in this area.
Where this research is happening
Hinckley, United States
- Icon Government and Public Health Solutions, INC. — Hinckley, United States (Active)
Researchers
- Principal investigator: Spitz, Robert — Icon Government and Public Health Solutions, INC.
- Study coordinator: Spitz, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.